Pre-PMF emerging as important subgroup of MPN
- PMID: 28620103
- DOI: 10.1182/blood-2017-04-777805
Pre-PMF emerging as important subgroup of MPN
Conflict of interest statement
Conflict-of-interest disclosure: H.G. receives research funding from Novartis and AOP Orphan, as well as speakers honoraria from Novartis, AOP Orphan, and Shire.
Comment on
-
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis.Blood. 2017 Jun 15;129(24):3227-3236. doi: 10.1182/blood-2017-01-761999. Epub 2017 Mar 28. Blood. 2017. PMID: 28351937 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources